MEDTOX Files 510(k) for Its New Sure-Screen Device

MEDTOX Scientific announced that it has filed a 510(k) application with the FDA for clearance to market its Sure-Screen drugs-of-abuse point-of-collection test (POCT) device. Sure-Screen is a POCT device intended to provide significantly lower detection levels for eight commonly abused drugs.

Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20050217005600&newsLang=en)